Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall fosamaxFosamax bone loss is a medical issue that has been in the news for several years. Fosamax (alendronate) belongs to the class of drugs called bisphosphonates, which are used to:
Other bisphosphonates available in the U.S. include Actonel, Boniva, Didronel, Aredia, Skelid, Reclast, and Zometa.
Fosamax Accumulates in the Body
Bisphosphonates may actually cause—rather than reduce the risk of—bone loss. Fosamax may cause bone damage when taken for long periods of time, perhaps because it accumulates in the body and remains in the body for years after its initial consumption. Fosamax and other bisphosphonates have been linked to bone loss and bone damage.
Fosamax and Osteonecrosis of the Jaw
Merck introduced Fosamax to the U.S. market in 1995. Since then, hundreds of patients who took Fosamax have developed a rare type of bone damage: osteonecrosis of the jaw (ONJ), a painful and lasting bone loss condition. ONJ can cause a partial or complete loss of bone tissue in the jaw. Many Fosamax-treated patients developed ONJ after having dental work done, but this is not a prerequisite for developing the condition.
There have been so many instances of ONJ following Fosamax treatment that a class action against Merck was attempted, but in early 2008 a federal judge denied class-action certification for the Fosamax litigation. Merck has been confronted with more than 400 individual Fosamax-ONJ lawsuits to date.
Fosamax Bone Damage
Another lawsuit alleging Fosamax bone damage was filed in early 2008 by a Connecticut resident who took Fosamax as prescribed on a daily basis for eight years. She suffers from severe pain and stress fractures in her legs, and needs a cane to walk.
Discuss Your Concerns with an Attorney
If you experienced bone loss after treatment with Fosamax, let an experienced attorney evaluate your case and inform you of your legal options.
A new study suggests that women taking the osteoporosis drug Fosamax are twice as likely to develop a chronic heart condition known as atrial fibrillat...
A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her l...
A lawsuit filed in a Florida federal court is claiming that Merck, the maker of Fosamax, was negligent in promoting its popular osteoporosis drug.
According to the complaint, Merck knew that Fosamax was defective but continuously concealed i...